Xanthine-based acyclic nucleoside phosphonates with potent antiviral activity against varicella-zoster virus and human cytomegalovirus
Jazyk angličtina Země Anglie, Velká Británie Médium print
Typ dokumentu časopisecké články
PubMed
30497281
PubMed Central
PMC6287304
DOI
10.1177/2040206618813050
Knihovny.cz E-zdroje
- Klíčová slova
- Acyclic nucleoside phosphonates, HCMV, PMEX, VZV, antiviral, xanthine,
- MeSH
- antivirové látky chemická syntéza chemie farmakologie MeSH
- Cytomegalovirus účinky léků MeSH
- lidé MeSH
- mikrobiální testy citlivosti MeSH
- molekulární struktura MeSH
- nukleosidy chemická syntéza chemie farmakologie MeSH
- organofosfonáty chemická syntéza chemie farmakologie MeSH
- virus varicella zoster účinky léků MeSH
- vztah mezi dávkou a účinkem léčiva MeSH
- vztahy mezi strukturou a aktivitou MeSH
- xanthin chemická syntéza chemie farmakologie MeSH
- Check Tag
- lidé MeSH
- Publikační typ
- časopisecké články MeSH
- Názvy látek
- antivirové látky MeSH
- nukleosidy MeSH
- organofosfonáty MeSH
- xanthin MeSH
While noncanonic xanthine nucleotides XMP/dXMP play an important role in balancing and maintaining intracellular purine nucleotide pool as well as in potential mutagenesis, surprisingly, acyclic nucleoside phosphonates bearing a xanthine nucleobase have not been studied so far for their antiviral properties. Herein, we report the synthesis of a series of xanthine-based acyclic nucleoside phosphonates and evaluation of their activity against a wide range of DNA and RNA viruses. Two acyclic nucleoside phosphonates within the series, namely 9-[2-(phosphonomethoxy)ethyl]xanthine (PMEX) and 9-[3-hydroxy-2-(phosphonomethoxy)propyl]xanthine (HPMPX), were shown to possess activity against several human herpesviruses. The most potent compound was PMEX, a xanthine analogue of adefovir (PMEA). PMEX exhibited a single digit µM activity against VZV (EC50 = 2.6 µM, TK+ Oka strain) and HCMV (EC50 = 8.5 µM, Davis strain), while its hexadecyloxypropyl monoester derivative was active against HSV-1 and HSV-2 (EC50 values between 1.8 and 4.0 µM). In contrast to acyclovir, PMEX remained active against the TK- VZV 07-1 strain with EC50 = 4.58 µM. PMEX was suggested to act as an inhibitor of viral DNA polymerase and represents the first reported xanthine-based acyclic nucleoside phosphonate with potent antiviral properties.
Institute of Organic Chemistry and Biochemistry Czech Academy of Sciences Prague Czech Republic
Laboratory of Virology and Chemotheraphy Rega Institute Leuven Belgium
Zobrazit více v PubMed
Bennett BD, Kimball EH, Gao M, et al. Absolute metabolite concentrations and implied enzyme active site occupancy in Escherichia coli. Nat Chem Biol. 2009; 5: 593–599. PubMed PMC
Wheeler LJ, Rajagopal I, Mathews CK. Stimulation of mutagenesis by proportional deoxyribonucleoside triphosphate accumulation in Escherichia coli. DNA Repair (Amst) 2005; 4: 1450–1456. PubMed
Arpaia E, Benveniste P, Di Cristofano A, et al. Mitochondrial basis for immune deficiency. evidence from purine nucleoside phosphorylase-deficient mice. J Exp Med 2000; 191: 2197–2208. PubMed PMC
Torres RJ, Puig JG. Hypoxanthine-guanine phosophoribosyltransferase (HPRT) deficiency: Lesch-Nyhan syndrome. Orphanet J Rare Dis 2007; 2: 48. PubMed PMC
Xu Y, Zheng Z, Gao Y, et al. High expression of IMPDH2 is associated with aggressive features and poor prognosis of primary nasopharyngeal carcinoma. Sci Rep. 2017; 7: 745. PubMed PMC
Hedstrom L. IMP Dehydrogenase: structure, mechanism, and inhibition. Chem Rev 2010; 109: 2903–2928. PubMed PMC
Welin M, Lehtiö L, Johansson A, et al. Substrate specificity and oligomerization of human GMP synthetase. J Mol Biol 2013; 425: 4323–4333. PubMed
Pang B, McFaline JL, Burgis NE, et al. Defects in purine nucleotide metabolism lead to substantial incorporation of xanthine and hypoxanthine into DNA and RNA. Proc Natl Acad Sci 2012; 109: 2319–2324. PubMed PMC
Shen J, Cheng Rideout WM, Jones PA. The rate of hydrolytic deamination of 5-methylcytosine in double-stranded DNA. Nucleic Acids Res 1994; 22: 972–976. PubMed PMC
Dedon PC, Tannenbaum SR. Reactive nitrogen species in the chemical biology of inflammation. Arch Biochem Biophys 2004; 423: 12–22. PubMed
Kamiya H. Mutagenic potentials of damaged nucleic acids produced by reactive oxygen/nitrogen species: approaches using synthetic oligonucleotides and nucleotides. Nucleic Acids Res 2003; 31: 517–531. PubMed PMC
Bass BL. RNA editing by adenosine deaminases that act on RNA. Annu Rev Biochem 2002; 71: 817–846. PubMed PMC
Palazzo AF, Lee ES. Non-coding RNA: what is functional and what is junk? Front Genet 2015; 5: 1–11. PubMed PMC
Rampazzo C, Miazzi C, Franzolin E, et al. Regulation by degradation, a cellular defense against deoxyribonucleotide pool imbalances. Mutat Res – Genet Toxicol Environ Mutage 2010; 703: 2–10. PubMed
Davies O, Mendes P, Smallbone K, et al. Characterisation of multiple substrate-specific (d)ITP/(d)XTPase and modelling of deaminated purine nucleotide metabolism. BMB Rep 2012; 45: 259–264. PubMed
Zheng J, Singh VK, Jia Z. Identification of an ITPase/XTPase in Escherichia coli by structural and biochemical analysis. Structure 2005; 13: 1511–1520. PubMed
Abolhassani N, Iyama T, Tsuchimoto D, et al. NUDT16 and ITPA play a dual protective role in maintaining chromosome stability and cell growth by eliminating dIDP/IDP and dITP/ITP from nucleotide pools in mammals. Nucleic Acids Res 2010; 38: 2891–2903. PubMed PMC
Davison AJ. Herpesvirus systematics. Vet Microbiol 2010; 143: 52–69. PubMed PMC
De Clercq E, Holý A. Acyclic nucleoside phosphonates: a key class of antiviral drugs. Nat Rev Drug Discov 2005; 4: 928–940. PubMed
Biron KK, Harvey RJ, Chamberlain SC, et al. Potent and selective inhibition of human cytomegalovirus replication by 1263W94, a benzimidazole L -riboside with a unique mode of action. Antimicrob Agents Chemother 2002; 46: 2365–2372. PubMed PMC
Gilbert C, Bestman-Smith J, Boivin G. Resistance of herpesviruses to antiviral drugs: clinical impacts and molecular mechanisms. Drug Resist Updat 2002; 5: 88–114. PubMed
Coen N, Duraffour S, Topalis D, et al. Spectrum of activity and mechanisms of resistance of various nucleoside derivatives against gammaherpesviruses. Antimicrob Agents Chemother 2014; 58: 7312–7323. PubMed PMC
Topalis D, Nogueira TC, Schutter T, et al. Resistance to the nucleotide analogue cidofovir in HPV(+) cells: a multifactorial process involving UMP/CMP kinase 1. Oncotarget 2016; 7: 10386–10401. PubMed PMC
Andrei G, Snoeck R. Herpes simplex virus drug-resistance. Curr Opin Infect Dis 2013; 26: 551–560. PubMed
De Clercq E, Holý A, Rosenberg I, et al. A novel selective broad-spectrum anti-DNA virus agent. Nature 1986; 323: 464–467. PubMed
Jindřich J, Holý A, Dvořáková H. Synthesis of N-(3-fluoro-2-phosphonomethoxypropyl) (FPMP) derivatives of heterocyclic bases. Collect Czech Chem Commun 1993; 58: 1645–1667.
Jansa P, Baszczyňski O, Procházková E, et al. Microwave-assisted hydrolysis of phosphonate diesters: an efficient protocol for the preparation of phosphonic acids. Green Chem 2012; 14: 2282–2288.
De Clercq E. The acyclic nucleoside phosphonates (ANPs): Antonín Holý's legacy. Med Res Rev 2013; 33: 1278–1303. PubMed
Česnek M, Masojídková M, Holý A, et al. Synthesis and properties of 2-guanidinopurines. Collect Czech Chem Commun 2006; 71: 1303–1319.
Yu KL, Bronson JJ, Yang H, et al. Synthesis and antiviral activity of methyl derivatives of 9-[2-(phosphonomethoxy)ethyl]guanine. J Med Chem 1992; 35: 2958–2969. PubMed
Holý A. Syntheses of enantiomeric N-(3-hydroxy-2-phosphonomethoxypropyl) derivatives of purine and pyrimidine bases. Collect Czech Chem Commun 1993; 58: 649–674.
Baszczyňski O, Hocková D, Janeba Z, et al. The effect of novel [3-fluoro-(2-phosphonoethoxy)propyl]purines on the inhibition of Plasmodium falciparum, Plasmodium vivax and human hypoxanthine–guanine–(xanthine) phosphoribosyltransferases. Eur J Med Chem 2013; 67: 81–89. PubMed
Franchetti P, Sheikha GA, Cappellacci L, et al. Synthesis and antiviral activity of 8-aza analogs of chiral [2-(phosphonomethoxy)propyl]guanines. J Med Chem 1995; 38: 4007–4013. PubMed
Holý A, Masojídková M. Synthesis of enantiomeric N-(2-phosphonomethoxypropyl) derivatives of purine and pyrimidine bases. I. The stepwise approach. Collect Czech Chem Commun 1995; 60: 1196–1212.
Holý A, Votruba I, Tloušťová E, et al. Synthesis and cytostatic activity of N-[2-(phosphonomethoxy)alkyl] derivatives of N6-substituted adenines, 2,6-diaminopurines and related compounds. Collect Czech Chem Commun 2001; 66: 1545–1592.
Reiser H, Wang J, Chong L, et al. GS-9219 – a novel acyclic nucleotide analogue with potent antineoplastic activity in dogs with spontaneous Non-Hodgkin's lymphoma. Clin Cancer Res 2008; 14: 2824–2832. PubMed
Daluge SM, Good SS, Faletto MB, et al. 1592U89, a novel carbocyclic nucleoside analog with potent, selective anti-human immunodeficiency virus activity. Antimicrob Agents Chemother 1997; 41: 1082–1093. PubMed PMC
Painter GR, Almond MR, Trost LC, et al. Evaluation of hexadecyloxypropyl-9-R-[2-(Phosphonomethoxy)propyl]- adenine, CMX157, as a potential treatment for human immunodeficiency virus type 1 and hepatitis B virus infections. Antimicrob Agents Chemother 2007; 51: 3505–3509. PubMed PMC
Jansa P, Baszczyňski O, Dračínský M, et al. A novel and efficient one-pot synthesis of symmetrical (bis-amidate) prodrugs of acyclic nucleoside phosphonates and evaluation of their biological activities. Eur J Med Chem 2011; 46: 3748–3754. PubMed
Holý A, Rosenberg I. Synthesis of 9-(2-phosphonylmethoxyethyl)adenine and related compounds. Collect Czech Chem Commun 1987; 52: 2801–2809.